Chicken-Pox: «Growing» Up Infection
https://doi.org/10.31631/2073-3046-2018-17-5-54-59
Abstract
Chicken pox in the Russian Federation in recent years has maintained a consistently high level of rating in the structure of infectious diseases and the magnitude of economic damage from infectious diseases.
Purpose: was to assess the epidemiological features of chicken pox in adults over 18 years in the Voronezh region.
Methods. Materials the study was of the form of Federal state statistical supervision over 2006 – 2017 years. The method of retrospective epidemiological analysis was used. Statistical data processing was performed using Microsoft Excel.
Results. In recent years, in the Voronezh region there has been an increase in the incidence and hospitalization of adults diagnosed with varicella. In persons older than 18 years, more severe course and complications were observed. Cases of varicella were reported as an infection related to medical care. The sources of infection for nosocomial cases were pregnant women and healthcare professional.
Conclusions. In order to prevent introduction and spread of chicken pox in medical organizations of the region it is necessary to consider the immunization of contingents at risk. It requires the introduction of a permanent statistical monitoring of individuals with a diagnosis of «Shingles».
About the Authors
T. N. SitnikRussian Federation
Tamara N. Sitnik – deputy. chief physician for epidemiology of the VRCC for AIDS Prevention and Control, assistant of the department of epidemiology, VSMU named after N. N. Burdenko.
8 (910) 2427356
L. V. Shteynke
Russian Federation
Lyudmila V. Steinke – Cand. Sci. (Med) assistant of the department of Epidemiology, VSMU named after N. N. Burdenko., Head. Department of Clinical Epidemiology, VRCC for AIDS Prevention and Control.
Tel. 8 (473) 270-52-79
N. V. Gabbasova
Russian Federation
Natalia V. Gabbasova – Dr. Sci. (Med),, associate professor, professor of the department of epidemiology.
394030, Voronezh, Donbass str., 1, Apt. 21, +7 (473) -252-37-13, +7 (906) 5896917
References
1. O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v Rossijskoj Federacii v 2016 godu: gosudarstvennyj doklad. Available at: http://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=8345 (in Russian).
2. Zryachkin N.I., Buchkova T.N., Chebotareva G.I. Сomplications of chickenpox (literature review). Journal Infectology. 2017; 9 (3): 117 – 128 (in Russian).
3. Ermolenko M. V. Serologicheskij monitoring v sisteme epidemiologicheskogo nadzora za vetryanoj ospoj: Doctorate of med. sci. diss. Moscow; 2014 (in Russian).
4. Kokoreva S.P., Ilunina L.M., Kazarceva N.V. Klinika i techenie vetryanoj ospy v sovremennyh usloviyah. Lechenie i profilaktika. 2016; 4: 13–20 (in Russian).
5. Voronin E.M., Ermolenko M.V., Chernova A.M., Lytkina I.N., Miheeva I.V. Sovremennye osobennosti epidemicheskogo processa vetryanoj ospy. Epidemiologiya i vakcinoprofilaktika. 2010; 6 (55): 17–23 (in Russian).
6. Virusnye bolezni: uchebnoe posobie. Ed.: N.D. Yushchuk,. Moscow : GEOTAR-Media. 2016: 640 (in Russian).
7. Sergeeva I.V., Lipnyagova S.V., Bekert A.I., Levickij S.V., Borisov A.G. Sovremennye osobennosti techeniya vetryanoj ospy. Sovremennye problemy nauki i obrazovaniya. 2015; 5. Available at: https://www.science-education.ru/ru/article/view?id=22220 (in Russian).
8. Vetryanaya ospa u vzroslyh: klinicheskie rekomendacii (protocol lechenia). Available at: http://nnoi.ru/uploads/files/protokoly/Vetr_ospa.pdf (in Russian).
9. Akimkin V.G., Salmina T.A., Volgin A.R., Shevtsov V.A., Korotchenko S.I., Kalabuhova L.Yu. Opyt primeneniya vakciny Varilriks dlya ehkstrennoj specificheskoj profilaktiki v ochage vetryanoj ospy. Epidemiologiya i vaktsinoprofilaktika. 2010; 1 (50): 67–71 (in Russian).
10. Sidel’nikov Yu.N., Zaporozhskij I.A., Slobodyanyuk S.N., Aseeva Yu.I. Ekonomicheskaya celesoobraznost’ vakcinoprofilaktiki vetryanoj ospy u voennosluzhashchih po prizyvu. Dal›nevostochnyj zhurnal infekcionnoj patologii. 2012; 21: 200–201 (in Russian).
11. Smol›yaninov S.V., Gnednev A.V., Sharipova L.F., Morozova N.N. O gruppovoj zabolevaemosti vetryanoj ospoj kursantov Voronezhskogo instituta MVD Rossii. Medicinskij vestnik MVD. 2014; 2 (69): 52–55 (in Russian).
12. Vetryanaya ospa u detej: pukovodstvo dlya vrachej. Ed.: N.V.Skripchenko, Sankt-Peterburg: TaktikStudio, 2015; 296 (in Russian).
13. Lamont R.F., Sobel J.D., Carrington D., Mazaki-Tovi S., Kusanovic J.P., Vaisbuch E. et al. Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG An International Journal of Obstetrics and Gynaecology. 2011. 118 (10):1155–1162.
14. Ilunina L.M., Kokoreva S.P., Demenkova A.A., Romanova O.O. Klinicheskie osobennosti nevrologicheskih oslozhnenij vetryanoj ospy. Materialy Rossijskoj nauchnoprakticheskoj konferencii «Aktual’nye problemy infekcionnoj patologii». Sankt-Peterburg. Zhurnal infektologii. 2017; 1 (9): 74 (in Russian).
15. Shah S.S., Wood S.M., Luan X., Ratner A.J. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010; 29:199–204.
16. Marin M., Zhang J.X., Seward J.F. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011; 128 (2): 214–20.
17. Weinmann S., Chun C., Schmid D.S., Roberts M., Vandermeer M., Riedlinger K., Bialek S.R., Marin M. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis. 2013; 208 (11): 1859–68.
18. Tseng H.F., Smith N., Marcy S.M., Sy L.S., Jacobsen S.J. Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008. Pediatr Infect Dis J. 2009; 28 (12): 1069–1072.
19. Edmunds W.J., Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect. 2002; 44 (4): 211–219.
20. Hardy I., Gershon A.A., Steinberg S.P., LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991; 325 (22): 1545–50.
21. Goldman G.S., King P.G. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine. 2013; 31 (13): 1680–1694.
22. Ong C.Y., Low S.G., Vasanwala F.F., Fook-Chong S.MC, Kaushik M., Low L.L. Incidence and mortality rates of varicella among end stage renal disease (ESRD) patients in Singapore General Hospital, a 12-year review. BMC Infect Dis. 2018; 18: 118.
23. Horn J., Damm O., Greiner W., Hengel H., Kretzschmar M.E., Siedler A., Ultsch B., Weidemann F., Wichmann O., Karch A., Mikolajczyk R.T. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study. BMC Med. 2018; 16 (1): 3. 24. Pritulina Yu.G., Salomahin G.G., Pegusov S.M. Techenie Herpes zoster na fone hronicheskih zabolevanij. Materialy Х Ezhegodnogo vserossijskogo kongressa po infekcionnym boleznyam. Moscow; 2017: 179 (in Russian).
Review
For citations:
Sitnik T.N., Shteynke L.V., Gabbasova N.V. Chicken-Pox: «Growing» Up Infection. Epidemiology and Vaccinal Prevention. 2018;17(5):54-59. (In Russ.) https://doi.org/10.31631/2073-3046-2018-17-5-54-59